Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshio Shima is active.

Publication


Featured researches published by Yoshio Shima.


Pediatrics International | 2013

Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease.

Yoshio Shima; Sakae Kumasaka; Makoto Migita

The aim of the study was to determine factors that affect adverse long‐term pulmonary outcome in premature infants.


Journal of Perinatology | 2011

Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants

Yoshio Shima; S Nishimaki; M Nakajima; S Kumasaka; Makoto Migita

Objective:To evaluate the clinical utility of urinary β-2-microglobulin (B2M) at birth, an alternative to proinflammatory cytokines, as an indicative marker of fetal inflammatory response and subsequent higher risk of bronchopulmonary dysplasia (BPD) in premature infants.Study Design:The relationship between urinary B2M at birth and the occurrence of BPD was examined in 96 premature infants with a description of perinatal backgrounds. Constructing a receiver-operating characteristic curve to determine the cutoff value of urinary B2M at birth for the development of BPD, a multivariate logistic regression analysis was performed to evaluate whether elevated urinary B2M at birth can be used as a predictor of BPD.Results:BPD was diagnosed in 34% (33/96) of the infants. Neonates with BPD had a significantly higher occurrence rate of chorioamnionitis and greater levels of median urinary B2M at birth than did those without BPD. The selected cutoff value of urinary B2M at birth correlated with the development of BPD, even after adjusting for gestational age and other confounding factors.Conclusions:Elevated urinary B2M levels at birth can be used as an alternative marker of fetal inflammatory response and subsequent higher risk of BPD in premature infants.


American Journal of Reproductive Immunology | 2017

Distribution of invariant natural killer T cells and dendritic cells in late pre-term birth without acute chorioamnionitis

Yasuyuki Negishi; Yoshio Shima; Toshiyuki Takeshita; Hidemi Takahashi

Acute chorioamnionitis (aCAM) is an important cause of pre‐term birth. However, little is known about the pathogenesis of late pre‐term birth without aCAM that was the most common category of pre‐term birth. Here we analyze the kinetics of immune cells obtained from the decidua of women with late pre‐term births with and without aCAM.


Biochemical and Biophysical Research Communications | 2009

Hematopoietic capacity of preterm cord blood hematopoietic stem/progenitor cells

Mizue Nakajima; Takahiro Ueda; Makoto Migita; Yuki Oue; Yoshio Shima; Takashi Shimada; Yoshitaka Fukunaga

Full-term cord blood (TCB) hematopoietic stem/progenitor cells (HSC/HPCs) are used for stem cell transplantation and are well characterized. However, the properties of preterm cord blood (PCB) HSC/HPCs remain unclear. In the present study, we compared HSC/HPCs from TCB and PCB with respect to their expression of surface markers, homing capacity and ability to repopulate HSCs in the NOD/Shi-scid mice bone marrow. The proportion of CD34+CD38- cells was significantly higher in PCB. On the other hand, the engraftment rate of TCB CD34+ cells into NOD/Shi-scid mice was significantly higher than PCB CD34+ cells. The expression of VLA4 was stronger among TCB CD34+ cells than PCB CD34+ cells. Moreover, there was a positive correlation between the proportion of CD34+CXCR4+ cells and gestational age. These data suggest that the homing ability of HSCs increases during gestation, so that TCB may be a better source of HSCs for transplantation than PCB.


Journal of Maternal-fetal & Neonatal Medicine | 2014

Postnatal changes of cytokines in premature infants with or without funisitis

Shigeru Nishimaki; Yoshio Shima; Miho Sato; Hiromi An; Keisuke Kadota; Shumpei Yokota

Abstract Objective: Fetal inflammatory response syndrome (FIRS), which induces hypercytokinemia, is important for the outcomes of premature infants. It is necessary to focus on the fetal inflammatory environments. Methods: A total of 37 premature infants (gestational age ≤32 weeks) were divided into three groups: (1) 15 without chorioamnionitis (CAM) and funisitis; C(−)F(−) group, (2) 15 with CAM but without funisitis; C(+)F(−) group and (3) 7 with CAM and funisitis; C(+)F(+) group. Blood interleukin (IL)-1β, IL-6 and IL-8 levels were measured on day 0 (= in umbilical cord blood), 3, 7, 14, 21 and 28. Results: (1) day 0: Cord blood concentrations of IL-1β, IL-6 and IL-8 were significantly higher in the C(+)F(+) group than in the C(+)F(−) group and C(−)F(−) group. On the other hand, they were comparable between the C(+)F(−) group and C(−)F(−) group. (2) Days 3–28: elevated cytokines levels in the C(+)F(+) group with funisitis decreased on day 3 and later. Conclusions: We suggested that hypercytokinemia in the cord blood in premature infants were greatly related with funisitis. Diagnosis of funisitis would be important to find the premature infants who need to be managed their risk of FIRS. In addition, hypercytokinemia disappeared in a few days after birth; therefore, cord blood data analysis of cytokines and/or inflammation-related proteins concentrations is necessary to evaluate the fetal inflammatory environments in premature infants after birth.


Archives of Gynecology and Obstetrics | 2009

Prenatal diagnosis of isolated congenitally corrected transposition of the great arteries

Yoshio Shima; Mizue Nakajima; Sakae Kumasaka; Makoto Migita

Congenitally corrected transposition of the great arteries (ccTGA) is a rare cardiac defect characterized by the atria connecting with anatomically discordant ventricles and the ventricles connecting with discordant and transposed great arteries, which allows hemodynamic compensation. Most patients with ccTGA have associated intracardiac anomalies, which could be a diagnostic clue, whereas isolated forms are infrequently diagnosed during the neonatal period and in utero. We describe a fetus that was diagnosed with ccTGA and without additional cardiac anomalies at 25 weeks of gestation. The parallel course of the great arteries discovered during a routine obstetric scan indicated this rare cardiac anomaly. Further detailed examination of the ventricular morphology helped to confirm the diagnosis. Despite hemodynamic compensation, the long-term prognosis of ccTGA is uncertain because of the possible development of arrhythmias or heart failure later in life. Our findings showed that fetal echocardiography can detect prenatal ccTGA.


Journal of Nippon Medical School | 2008

Risk Factors for Transient Tachypnea of the Newborn in Infants Delivered Vaginally at 37 Weeks or Later

Akane Takaya; Miwa Igarashi; Mizue Nakajima; Hidehiko Miyake; Yoshio Shima; Shunji Suzuki


Journal of Nippon Medical School | 2001

Massive Subchorionic Hematoma (Breus' Mole) Complicated by Intrauterine Growth Retardation

Naoko Nishida; Shunji Suzuki; Yukie Hamamura; Kenji Igarashi; Zuisei Hayashi; Rintaro Sawa; Yoshio Yoneyama; Hirobumi Asakura; Ken Kawabata; Yoshio Shima; Sumio Shin; Tsutomu Araki


Journal of Nippon Medical School | 2008

An Infant with Congenital Nemaline Myopathy and Hypertrophic Cardiomyopathy

Mizue Nakajima; Yoshio Shima; Sakae Kumasaka; Kentaro Kuwabara; Makoto Migita; Yoshitaka Fukunaga


Obstetrics & Gynecology | 2001

Mesenchymal stem villous hyperplasia of the placenta and fetal growth restriction.

Yoshimitsu Kuwabara; Yoshio Shima; Tsutomu Araki; Sumio Shin

Collaboration


Dive into the Yoshio Shima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge